Last summer when the Agent Orange Act was coming to expire, 53 of us co-sponsored that and it ended with a whimper without even a floor vote.

But I would suggest to my colleagues here, why were we so willing to give up to the executive branch the authority to make these decisions, and why we gave away our power with the expiration of the Agent Orange Act.

I think we need to take more of the lead on this. I think we need to make sure, because I think as science moves along, the research possibilities are still out there, and I think we are shutting doors.

Madam Chair, I thank the gentleman for yielding time. I rise in support of the SHARE Act and the Sportsmen's Heritage and Recreational Enhancement Act. I thank my co-chair on the Sportsmen's Caucus, Mr. Wittman, for his work on this bill…

I think our issue, especially with these toxic wound exposures in battle, it differs from cancer...

I think it's important information with the hearing that's going to be next week up in New Hampshire with Ms. Kuster.

My concern is, though, when do we make a decision that we've tried hard enough or that we've reached that point.

I know in this case that the commitment from the VA is there to get this on the forefront.

I think it is probably happening. But there is a disconnect between that, the private sector pain management experts.

We treat addiction after it is there, good luck.

Mr. Speaker, as you have heard, I associate myself with the remarks of the positive nature of the provisions in this bill. It has been the House Veterans' Affairs Committee that has been in the forefront of improving veterans care, from…